Genocure AI

Genocure AIGenocure AI
Genocure AI

Genocure AI

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Website
DR 112023ActiveSan Francisco, United States
Rate
Advertise here

About

Genocure AI combines next-generation genomics with powerful AI to guide smarter, personalized cancer treatments. Their advanced precision oncology platform, Supreme™, integrates multi-omic data with AI-driven algorithms to identify optimal therapeutic combinations for individual patients. They serve healthcare providers and the pharmaceutical industry, with future plans to assist patients directly.
Frequently asked

What does Genocure AI do?

Genocure AI combines next-generation genomics with powerful AI to guide smarter, personalized cancer treatments. Their advanced precision oncology platform, Supreme™, integrates multi-omic data with AI-driven algorithms to identify optimal therapeutic combinations for individual patients. They serve healthcare providers and the pharmaceutical industry, with future plans to assist patients directly.

What is Genocure AI's revenue?

StartupHub estimates Genocure AI's annual revenue at $2.9M (range $683K to $4.2M, 27% confidence), based on comparable companies in the sector.

What is Genocure AI's valuation?

StartupHub estimates Genocure AI's effective valuation at $39.2M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.

How much funding has Genocure AI raised?

Genocure AI has raised a total of $10M in funding. The most recent round on record is Seed.

Where is Genocure AI headquartered?

Genocure AI is headquartered in San Francisco, United States.

When was Genocure AI founded?

Genocure AI was founded in 2023.

What industry does Genocure AI operate in?

Genocure AI operates in Life Sciences, Oncology, Biotech, Drug Discovery, AI-Driven Drug Discovery, Foundation Model.

Comments

No comments yet. Be the first to share your take.